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Abstract. A total of 23 newかsynthesizedふ aminomethylene幽 
3(2lf介benzofuranoneand stntctural.か刊 latedcompounds were 
compared for their C}制 ox!cact!v!ぴ againstboth no開 αl 
(human gingival fibroblast HGF) and tumor cels、 (humanoral 
squamous celllines HSC-2，HSι3 and humαn salivary gland 
tumorεels HSG). There was a significant variability of dmg 
sensitiviちI among the oral tumor celllines. ln general，HSι2 
cels were the most sensitive，foU倒 ledby HSG cell.s， while HSC-
3 cels were the most re苫 istant. HGF nonnal αl.s were highly 
resistant to al C01rψounds， su， theirtumor-speci声C銀総lIr啄 
cytotoxic action. The cytotoxic activiぴ ofthe εompounds with 
morpholine， 1・methy在中 erazineor pなJeridinestmcture was 
generalか elevated tぴ theintroduεtion of fluorine， but not 
chlorine and methαxyfunctional groups，to the benz，φ /ranone 
stmcture， whereas that of compounds at，αched by 1ァhe-
Fりかそ perazineor 1-(2-pyri砂 l)piperω， inewas rather reduced. The 
most active compounds induced intemucleosomal DNA 
fragrη entation in human promyelocytic leukemia HL-60 cels， 
but not in HSG，further confinning that oral tumor celllines are 
resistant to DNase digestion. 
To find eff巴 ctive antitumor agents for treating oral 
carcinoma，we have註 doptedthe following three strategies: 
(i)screening of active substan部 s(both natural and synthetic)， 
(i) mechanism of cytotoxic action (either apoptosis or 
necrosis)，and (ii) interaction with oral environment. We 
have reported the cytotoxic activity of polyphenols， 
antioxidants and vita税制字情 3).We have recent年 foundthat 
benzothiepins，benzoxepins 総 d 5-benzoylimidazoles (4-6) 
showed higher cytotoxic activity 註喜 ainsthum鉛 oral tumor 
cell lines (humaぉ squ設mouscell carcinoma HSC-2，HSC-3， 
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human salivary gland tumor HSG) than against human 
normal gingival fibroblast HGF， suggesting their tumor-
specific cytotoxic action. Aurone， which has a知的-
benzofuranone structure attached by benzene ring，has shown 
in vitro leishmanicidal activity (7) and slightly inhibited the 
topoisomerase I-catalysed DN八 religation (8). Dihydro-
benzofuranones have shown antiulcer activity (9，10). . 
We have newly synthesized a series of aminomethylene-
benzofuranone derivatives which contain the piperidine ring司 
instead of the benzene ring (11). We investigated here the 
structure-activity relationship of these compounds，using in 
vuro cytotoxicity as悶 ywith both normal and tumor cells. 
提訴 eI泌 sand誠意 thods 
Materials. The following reag記昂 tswere obtained from the indicated 
companies: Dulbecco'事 modified E昌義 lemedium (DMEM)，RPMI1640 
medium (Gibco BRL，Gland Island，NY，じ SA);た talbovine serum 
(FBS) (JRH Biosci，Lenexa，KSラ USA);dimethyl s註 lfoxide(DMSO) 
(Wako Pure Chem. Ind. Ltd.，Osaka，Japan); 3-いふ dimethylthiazol-2-
yl]-2，5-diphenyl tetrazolium bromide (M'行) (Sigma Chern. lnd.，St. 
Louis，MO，USA); RNase A，proteinase K (Boehri時 erMannheim， 
G巴 rmany). 
Synthesis of 2叫 minomethylene剛 3(21力“ benzof主ranone(general proce似，re). 
To a mixture of 3叶 odochromone (1 rnmol) and K2C03 (1.4 g，10 mmol) 
inDMF (10 mし) was added a solution of a secondary amine (1.5 mmol) 
in DMF (2 mL) at room ternperature. After being stired for 1-3.5 hour民 
the reaction mixture was diluted with iced-water and extracted with 
CHC13 (20 mL x 3). The organic layer was dried over NaZS04 and the 
solvent was evaporated under reduced pressure. The residue was 
purified by silica gel eolumn chromatography (hexane/AcOEt 
with gradual increase of ethyl acetate) to afford the 2-aminomethylenゃ 
3(2H)-benzofurano担ふ 
Synthesis of 2てpiperidinomethylene-3(2H)-benzofuranone{la]. Acωrding 
to th器 generalprocedure，3-iodochrornone (272 mg， 1 mmol) and 
piperid磁器 (128rng，1.5 rnrnol) were treated with K2C03 for 1 hourω 
茎ivela (220 絞ら%後} 
Synthesis of 5-methoxy-2-pipelidinomethylene-3βH)み enzoftlranone[1bJ. 
According to the ge読む主主 1proced註 re，3-iodo-6-methoxychromone (302 
5 mmol) were treated with 1.喜，1 mmol) and piperidine (128 m，mg 
K2C03 for 1 hour 10草ivelb (236 mg，91%). 
Synthesis of 6-methoxyω乙piperiゐ，nomethylene-3(2H)み enzofuranone{lcj 
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pecificityof 2-aminomethylene_ 司andtumor砂Cytotoxic activi 1. Table3-iodo-7-methoxychromone (302 ，According to the general procedure
mg， 1 mmol) and piperidine (128 mg， 1.5 mmol) were treated with 3ρH)-benzofuranones 
KZC03 for 2 hours to give lc (243 mg， 84%)ー 
Synthesis of 5グ 'uoro-2-piperidinomethylene-3(2H)-benzofuranone [ld] 
Accordi珂 tothe general procedure， 6-t1 uoro-3-iodochromone (290 mg， 
1 mmol) and piperidine (128 mg， 1.5 mmol) were treated with KZC03 
for 1 hour to give ld (207 mg， 84%) 
Synthesis of 2-pY'TOlidinomethylene-3(2H) -benzofuranone ρaJ. According 
to the general procedure， 3-iodochromone (272 mg， 1 mmol) and 
pyrrolidine (107 mg， 1.5 mmol) were treated with KZC03 for 2 hours to 
give 2a (189 mg， 88%). 
Synthesis of 2-hι xamethyleneiminomethylene-3 (2H) -benzofuranone β aJ. 
Accordi時 tothe general pro∞ dure， 3-iodochromone (272 mg， 1 mmol) 
and hexamethyleneimine (149 mg， 1.5 mmol) were treated with KZC03 
for 1 hour to give 3a (231 mg， 95%) 
Synthesis of 2-morpholinomethylene-3(2H)-benzofuranone [4aJ. A ∞ ording 
to the general procedure， 3-iodochromone (272 mg， 1 mmol) and 
morpholine (131 mg， 1.5 mmol) were treated with K2C03 for 1 hour to 
give 4a (203 mg， 88%) 
Synth回目。>/ 5-methoxy-2-mo円pholinomethylene-3(2H)-benzofuranone[4b] 
Accordi時 tothe general procedure， 3-iodo-6-methoxychromone (302 
mg， 1 mmol) and morpholine (131 mg， 1.5 mmol) were treated with 
K2C03 for 2 hours to give 4b (238 mg， 91%) 
Synthesis of 6-methoxy-2-mo円pholinomethylene-3(2H)-benzofuranone[4c]. 
According to the general procedur弘子 iodo-7-methoxychromone(302 
mg， 1 mmol) and morpholine (131 mg， 1.5 mmol) were treated with 
KZC03 for 3.5 hours to give 4c (243 mg， 93%). 
Synth白山 of5-fluoro-2-mo円pholinomethylene-3(2H)-benzofuranone[4d] 
Accordi時 toth巴 generalprocedure， 6-t1 uoroふ iodochromone(290 mg， 
1 mmol) and morpholine (131 mg， 1.5 mmol) were treated with K2C03 
for 1 hour to give 4d (224 mg， 90%) 
Synthesis of 2-thiomo円pholinomethylene-3(2H)伽 zofuranone[5a J.According 
to the general procedure， 3-iodochromone (272 mg， 1 mmol) and 
thiomorpholin巴 (155mg， 1.5 mmol) were treated with K2C03 for 1 hour 
to give 5a (217 mg， 88%). 
Synthesis of 2-[(4-methy~ロiperazino )methylene] -3(2Hrbenzofuranone 
[6aJ. According to the general procedure， 3-iodochromone (272 mg， 1 
mmol) and l-methylpiperazine (150 mg， 1.5 mmol) were treated with 
K2C03 for 1 hour to give 60 (220 mg， 90%) 
Synthesis of 5-methoxy-2-[(4-methy~ロ iperazino)methylene]-3(2H)-benzo-
furanone [6bJ. According to the general procedure， 3-iodo-6-metho-
xychromone (302 mg， 1 mmol) and l-methylpiperazine (150 mg， 1.5 
mmol) were treated with KZC03 for 2 hours to give 6b (238 mg， 87%) 
Synthesis ofι methoxy-2-[(4-methy~ロiperazino)methylene]-3 (2H)-benzofu-
ranone [6cJ. According to the general procedure， 3-iodo-7-metho-
mmol) were 
xychromone (302 mg， 1 mmol) and l-methylpiperazine (150 mg， 1.5 
88%)，hours to give 6c (241 mg .5 3 for 2∞treated with K2 
Synthesis of 5てfluoro-2-[( 4-methyljヲ iperazino)methylene] -3 (2H) -benzofu-
ranone [6dJ. According to the general procedure， 6-日 uoro-3-
iodochromone (290 mg， 1 mmol) and l-methylpiperazine (150 mg， 1.5 
mmol) were treated with KZC03 for 1. 5 hours to give 6d (246 mg， 94%) 
Synth目 isof 2-[(4-phenylpiperazino)methylene]-3(2H)-benzφiranone [7aJ. 
According to the general procedure， 3-iodochromone (272 mg， 1 mmol) 
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匂 totoxic activi旬 (CCso附 mL) 
TumOI 
Compound HSC-2 HSC-3 HSG HGF specificity 
(A) (B) B/A 
ExpJ 
la 310 359 104 369 1.1 9 
lb 227 244 123 360 1. 59 
lc 173 230 111 350 2.02 
ld 125 120 148 347 2.78 
2a 348 373 200 391 1.1 2 
3a 144 176 135 281 1. 95 
4a 498 461 224 >500 >1. 00 
4b 490 490 236 448 0.91 
4c 231 >500 232 >500 >2.16 
4d 244 >500 222 >500 >2.05 
5a 261 238 186 332 1. 27 
60 >500 >500 433 >500 > <1. 00 
6b >500 >500 383 >500 ><1. 00 
6c 348 >500 390 >500 >1. 44 
6d 125 307 292 >500 >4.00 
70 46 93 104 250 5.4 3 
80 73 139 85 184 2.52 
Exp.II 
7a 78 442 156 153 1. 96 
7d 144 455 163 219 1. 52 
7e 295 >500 417 365 1. 24 
7f 188 439 356 293 1. 56 
80 121 176 94 146 1. 21 
8d 399 >500 304 383 0.96 
8e 179 >500 452 393 2.20 
8f 38 386 167 346 9.1 1 
Near cont1 uent cels were incubated for 24 hours with various 
concentrations of each compound. The relative viable cel number was 
then determined by MTT method. Control AS40 of HSC-2， HSC-3， HSG 
and HGF cels was 1. 22， 2.00， 0.89 and 0.3 1， respectively. Each value 
represents the mean from 2 independent experiments which were done 
in duplicate. 
and l-phenylpiperazine (243 mg， 1.5 mmol) were treated with KZC03 for 
2 hours to give 7a (285 mg， 93%) 
Synthesis of 5-fluoro-2-[(4-pheny~ロiperazino)methylene]-3(2H)-benzofura­
none [7dJ. According to the general procedure， 6-t1 uoro-3-iodochro-
mone (290 mg， 1 mmol) and l-phenylpiperazine (243 mg， 1.5 mmol) 
were treated with KZC03 for 1 hour to give 7d (214 mg， 66%) 
r: 
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2aminomethylene-3(2H)自治 nzofuranone幅 
統	 R'::;R2::;R3::;対 
R'::;R3=H， 
c:R'ロ R2:H.R 3::;OMeR2平ド b: R2=OMe 
ト-1， R1=R3d: = R2=F 
e:R'器 R3:;H， R2=Cl 
1-8 f: R'::;内 3::;OMe， R2::;H 
Oompd. No 1 	R'NR2Oompd. No. R2 F司3	 NR2 R1 R2 F司3 
町、f
N N Me
J、叩 1a 	 行 行 村 H事事 行 行 NJ 
一、f
1b NJ 
十t OM告 十t 6b 干場、-'N Me 
行 O Me H 
lc 	 H O Me " 6c N、岬ノ NM申 H H O MeNJ “ 
1d 	 H F H 6d N、-'NM砧 十1 F H "NJ 
cht。。。。
 
2調 NJ H H 十4 7a 行 H H 
H F 行 
H 01 トf 
OMe H OMe 
Sa {) H H 行 7d 
4a NrL-、 H H HJO 7e 
f側、
4b 	 H OMe H 7fNLJ 
へfJ司、 』 H 十f O Me 自 a CN〈コ4c H H H 
4d F4f、脚ーノ O 付 F 行 
f町、 
5a N1-JS 
れ 行 H 
Bd 	 H F HOQ
嘗 a CN H 01 村〈〉 
器開 CN OMe H O Me〈〉 
1 
Figure 1. Structure Df2-aminDmethylene-3(2H)benzDfuranDne伊 
Synth倒 is Df 5-chlorD-2-[(4てpheny/pipenが inD)methylene]-3(2H)-benzo.長則自 [8a]. Accordi勾 10the general proccdure，3-iodochromone (272 mg， 1 
nDne [7e]. According to the general procedure， ふ chloroふ iodか mmo1) and 1-(2-py凶 yl)piperazinc(245誌を g，1. 5 mmol) were tre昌 tcdwith 
1%).，号mg歩K2C03 for 1hour to give 8a (27rnrnol) .51，henylpiperazine(243 rngゃ1級品chromone (307 mg. 1mrnol)
were Irむ ated開 thK2C03 for 1hour 10 give 7e (100 mg，29%). 
Syn仇 esis Df 5タ 'uDrD-2-{[4イ 2-pyridyl)pipeT立 zinD]methylene}-3(2H)-ben-
ふ6-fluoro	3(2H)-ben-・.jperazinD)methylene]なフ 2-/(4-pheny砂o.6-dimeth，Synthesis Df 4 zDfuranDne [8d]. According 10 the general proced証 re， iodo-
zDfuranDne [初 According 10 the general procedure， 3-iodoδユ chrorno詰 e(290 rng， 1 mrnol) and 1-(2判 ridyl)piperazine(245 mg， 1.5 
dirnel註 oxychromone(332 mg，1 mrnol) and l-phen)ヤ iperazine(243 rng， rnrnol) were treated wIth K2C03 for 1hour to g附結 (207mg，64%). 
3(2H)-benzD}・ 2-pylidyl)piperazino]methyleneイ[4ぺchlDro-2ふSynthesis Df 
る).'f82，to give 7f(301 rngour註were treated with K2C03for 1	5 mrnol)1.
“
今 mhesisofみ {[4イ 2てpyriの l)piperazino]methylene}-3ρH)-benzDfuranone か ranone[8e]. Ac∞ rdin草 tothe general proむ edure，か chloro-3-iodo-
3373 
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4 6 8 10 12 
HSG 
HL-60 
7a 8a 8f 
7a 8a 8f 
246 8 10 12 
n H aKM 
切りhours with 0 (cont.6'luentHL-60 and HSG cels were Incubatedforザ8a and 8f. Near COf，α，n ofDNA fragmentation by compounds 7ωInduct 2. re芸誌Fi 
(Iane 1，5，9)，100 (lanes 2，6，10)，200 (l.削出、 3， DNA9-12).alles(l8)or 8f・8a (Ianes 5，のLofcompoulld 7a (lales 1付加12)，説I). or 400 (Ianes 47， 
wω then extracted alld subjected的 2劣 lagα，rosegel electrophoresis. M， marker DNA 
51.，yridyl)piperazine(245 mgゅ， 1mmol) and 1-(2ふchromone (307 m
).宅'b24 mι36(1were treated with K2C03 for 1hour 10 give 8emmol) 
SYllthesis of 4，6-dimetho.ゅ 2-{[4-(2“pyril今 1)piperazinoJr配 thylene}-3(2H) 
，3-iodoδ，According to the general procedurefJ-[.者 /lebellzofu.rano 7剛 
dimethoxychromo琵 e(332 mg，1mmol) and 1-(2・pyridyl)piperazine(245 
m喜多1.5mmol) were Ireated with K2C03 for 1主ourto give 8f (302 mg， 
82%ト 
Cell culture. H技館主 noral squamous cel carcinoma (HSC-2，HSC-3) and 
human salivary gla註 dtumor (HSG) cels and 加 mangingival fibroblast 
(HGF) (7θth passage) were cultured in DMEM medium supplemented 
with 10 % heat-inactivated FBS in a humidified 5% C02 atmosphere 
Human promyelocytic leukemia HL-品。 αlls were cultured in 1えPMI1640 
medium supplemented with 10% FBS (4引， 
A~:Yay for cytotoxic activity. Near confluent cels grown泌 96-microwell 
plate (Falcon，筑波 bottom， tre註 tedpolystyren民 BectonDickinson) were 
incubated for 24 hours w油 vanousωncentrationsof samples 花 eel1s 
were washed with phosph器 tゃ bufferedsali泌 (PBS)，and incubated for 4 
hours with fresh cu1ture med泌 mcontaining 0.2 mgimL MつIT. After 
removing the medium，the cels官 er記 lysedwith 1以oIAl DMSO and出 c 
rξlative viable cel number was determined by measuring the品 bsorbanee 
at 540 nm ofthc cellysate with th巴Labsystem ちをultiskan~(日 iochro磁波 ic) 
with a Star/DOT Matrix Pri紙記 rJL-lO. The 50% cytotoxic concentration 
(CC50) was determined from the dose-response curve (ふる). 
Assayfor DNA介'Ilgmentatioll.The cels were pelletedlysedand digestedう 
with RNase A and proteinase K. DNA w泌総 olatedand assayed for 
DNA fr器 gmentationby 2% agarose gel electrophoresお (5、 10).The 
DNA sIze marker (GIBCO B災 L)(Cat. No. 10380-012) was run in 
paralel. 
3374 
Results and DiscussIon 
Twenty-three 2-aminomethylene-3(2H)-benzofurano服部 d 
structurally-related compounds (Figure 1) were compared for 
their cytotoxic activ均 againstboth normal (hむ mangingival 
1∞fibroblast HGF) and tumor cels (human oral squamous 
lines HSC司 2，HSC-3 and human saliv孟ry gland tumor cels 
HSG).立 lerewas a significant variability of drug sensitivity 
among oral tumor celllines. In gcneral，HSC2cels were the欄 
most sensitivc，follow♀ d by HSG celsラ whileHSC-3 cels w容 re 
the most resistant. HGF cels were highly resistant to al 
compounds，suggesting their tumor-specific cytotoxic action. 
The cytotoxic activity of benzofur'anones was relatively weak， 
as compared with benzothiepins [4]設 ndbenzoylimidazoles 
[5]. Si詮 cewe have found the synergistic action of be山 0-
thicpins and 加 it might be beneficial to 喜多 ticancerdrug
investigate such combination effects of benzofuranones and 
anticancer drugs.ηle cytotoxic activity of benzofuranones， 
]， pyrrolidine [2a，ldJ，lc，lb，vepiperidine [la設which h
l.4d，4c，4b，[4amorpholine ]， hexamethyleneimine [3a
thiomorpholine [5aJ orト methyヤ iperadine[6a，6b，6c，6d] 
structures，were generally enhanced by the introduction of the 
fluorine functional group，whereas that of compounds which 
have 1刊 lenyヤ iperazine[7a，7d，7e，7f] or 1-(2働 pyridyl) 
piperazine [8a，8d，8e，8f] was not affect記 dby the fluorine 
functional group. These dat設 suggestthat the addition of the 
I!'. 	 『吋 
Terasawa et a[; 
fluorine functional group differently modified the cytotoxic 
activity of the compounds， depending upon their three-
dimensional structure. The most active compounds (7a，8a， 
8fj induced internuc1eosomal DNA fragmentation in human 
promyelocytiむ leukemiaHL-60 cellsヲ butnot in HSG cells 
(Figure 2). Wむ havepreviously reported that 刊行 0悶 natural 
and synthetic ∞ mpounds failed to induce internuc1eosomal 
DNA fragmentation in oral tumor cell lines，in contrast to 
human leukemic cells (1δ). This suggests that chromatin 
DNA of oral tumor celJs might be resistant to DNase註 ttack 
(12， 13)，or DNasむ cannot be fuUy activated by treatment 
with these agents. 
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